Published online Jul 20, 2022. doi: 10.5662/wjm.v12.i4.305
Peer-review started: December 6, 2021
First decision: January 25, 2022
Revised: January 31, 2022
Accepted: June 26, 2022
Article in press: June 26, 2022
Published online: July 20, 2022
Processing time: 225 Days and 19.2 Hours
The prevalence of human leishmaniasis varies widely in different countries and in different regions of the same country. To date, there is no overall estimation of the prevalence of human leishmaniasis in Sudan
The lack of evidence about human leishmaniasis in Sudan may prevent health care policymakers and stakeholders from developing and adopting a suitable prevention program.
The objective of this study was to find the pooled prevalence of leishmaniasis and its associated factors among Sudanese citizens.
A systematic literature search was conducted before the 4th of August 2021, from Scopus, Web of Science, PubMed, and MEDLINE, African Journals Online (AJOL), ResearchGate, direct Google search, Google Scholar, and universities websites.
A total of 20 articles were included in this meta-analysis after 220 articles had been subjected to full-text evaluations, and the overall pooled prevalence of human leishmaniasis in Sudan was 21% (with confidence interval 12%-30%).
Human leishmaniasis infection is still endemic in many regions in Sudan and is highly prevalent in central and eastern Sudan, and cutaneous leishmaniasis is the most prevalent in the country.
More studies need to be done in Sudan to cover all epidemiological aspects of the disease in humans and animals under the umbrella of one health approach, with special emphasis on the health and economic impacts of the disease.